Hematopoietic Cell Transplantation in Diffuse Large B‐cell Lymphoma - Cancer Consult: Expertise for Clinical Practice - Wiley Online Library

National Director of Medical Oncology, Cancer Treatment Centers of America; Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA

Search for more papers by this author

First published: 20 June 2014

https://doi.org/10.1002/9781118589199.ch52

Summary

This chapter presents a case study with questions and answers on hematopoietic cell transplantation in diffuse large B-cell lymphoma (DLBCL). It commences with a discourse on the therapeutic and prognostic implications, especially of molecularly defined “ABC high-risk” lymphoma, and ends with the discussion on the prevention of relapse after autologous transplant. The chapter discusses the two cycles of R-DHAP and achieved complete response (CR2). It tabulates the experimental agents under investigation in DLBCL.

References

Cancer Consult: Expertise for Clinical Practice